Publications by authors named "Henry Conter"

Claim this Profile
M
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world data.
Adam M Brufsky, Kent F Hoskins, Henry J Conter, Pond Kelemen, Mehran Habibi

JNCI Cancer Spectr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D.
Evan Y Yu, Cristiano Ferrario, Mark D Linch, Michael Stoeckle, Brigitte Laguerre, Henry J Conter

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer.
Arif Ali Awan, Carol Stober, Gregory R Pond, Igor Machado, Lucas Clemons, Henry Conter

Breast Cancer Res Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Scoping Review of the Current Knowledge of the Social Determinants of Health and Infectious Diseases (Specifically COVID-19, Tuberculosis, and H1N1 Influenza) in Canadian Arctic Indigenous Communities.
Fariba Kolahdooz, Se Lim Jang, Sarah Deck, David Ilkiw, Gertrude Omoro, Henry J Conter

Int J Environ Res Public Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study.
Evan Y Yu, William R Berry, Howard Gurney, Margitta Retz, Henry J Conter

Eur Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysis.
Mufiza Farid-Kapadia, Madelyn Barton, Zoe Bider-Canfield, Parneet K Cheema, Bishal Gyawali, Henry J Conter

Future Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study.
Evan Y Yu, Michael P Kolinsky, William R Berry, Margitta Retz, Loic Mourey, Henry J Conter

Eur Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre.
Parneet K Cheema, Marco A J Iafolla, Massey Nematollahi, FeRevelyn Berco, Deepanjali Kaushik, Henry J Conter

Curr Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.
Arif Awan, Terry Ng, Henry Conter, William Raskin, Carol Stober

J Bone Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial.
Robert Jotte, Federico Cappuzzo, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodríguez-Abreu, Henry J Conter

J Thorac Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of written feedback given to medical students after introduction of real-time audio monitoring of clinical encounters.
Michael Sanatani, Kylea Potvin, Henry Conter, Kimberly Trudgeon, Andrew Warner

BMC Med Educ· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.
Fred Saad, Christina Canil, Antonio Finelli, Sebastien J Hotte, Shawn Malone, Henry J Conter

Can Urol Assoc J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management algorithms for metastatic prostate cancer.
Shawn Malone, Bobby Shayegan, Naveen S Basappa, Kim Chi, Henry J Conter

Can Urol Assoc J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.
Sebastien J Hotte, Anil Kapoor, Naveen S Basappa, Georg Bjarnason, Christina Canil, Henry J Conter

Can Urol Assoc J· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.
Howard West, Michael McCleod, Maen Hussein, Alessandro Morabito, Achim Rittmeyer, Henry J Conter

Lancet Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces.
Dixon T S Woon, Thenappan Chandrasekar, Lorne Aaron, Naveen S Basappa, Kim N Chi, Henry J Conter

Can Urol Assoc J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.
M Neil Reaume, Naveen S Basappa, Lori Wood, Anil Kapoor, Georg A Bjarnason, Henry J Conter

Can Urol Assoc J· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical first-line management of renal cell carcinoma in a community practice.
Henry Conter

Can Urol Assoc J· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience.
Henry J Conter, Vancheswaran Gopalakrishnan, Vinod Ravi, Joann L Ater, Shreyaskumar Patel

Sarcoma· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission.
Henry J Conter, Zita D Lim, Chaan S Ng, Randall E Millikan, Nizar M Tannir

Clin Genitourin Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of financial relationships in economic analyses of targeted therapies in oncology remains unclear.
Henry Jacob Conter

J Clin Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wise Investment? Modeling Industry Profitability and Risk of Targeted Chemotherapy for Incurable Solid Cancers.
Henry J Conter, Quincy S C Chu

J Oncol Pract· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trust for treatment.
Henry Jacob Conter

J Cancer Educ· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty years of meta-analyses in orthopaedic surgery: has quality kept up with quantity?
Bernadette G Dijkman, Jihad A K Abouali, Bauke W Kooistra, Henry J Conter, Rudolf W Poolman

J Bone Joint Surg Am· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Values-based health care debate, not statistics.
Henry J Conter

CMAJ· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis